Abstract
Matrix metalloproteinase-1 (MMP-1) is critical for mediating breast cancer metastasis to bone. We investigated the role of MMP-1 in breast cancer invasion of soft tissues and bone using human MDA MB-231 breast cancer cells stably transfected with shRNAs against MMP-1 and a novel murine model of bone invasion. MMP-1 produced by breast cancer cells with control shRNA facilitated invasion of tumors into soft tissue in vivo, which correlated with enhanced blood vessel formation at the invasive edge, compared to tumors with silenced MMP-1 expression. Tumors expressing MMP-1 were also associated with osteolysis in vivo, whereas tumors with inhibited MMP-1 levels were not. Additionally, tumor-secreted MMP-1 activated bone-resorbing osteoclasts in vitro. Together, these data suggest a mechanism for MMP-1 in the activation of osteoclasts in vivo. We conclude that breast cancer-derived MMP-1 mediates invasion through soft tissues and bone via mechanisms involving matrix degradation, angiogenesis, and osteoclast activation.
Similar content being viewed by others
Abbreviations
- ATCC:
-
American Type Culture Collection
- CM:
-
Conditioned media
- DHMC:
-
Dartmouth-Hitchcock Medical Center
- HMVECs:
-
Human microvessel endothelial cells
- HPRT:
-
Hypoxanthine-phosphoribosyl transferase
- H&E:
-
Hematoxylin and eosin
- IHC:
-
Immunohistochemistry
- LH:
-
Lactalbumin hydrolysate
- LRR:
-
Local/regional recurrence
- M-CSF:
-
Macrophage colony stimulating factor
- MMP:
-
Matrix metalloproteins
- RANKL:
-
Receptor activator of NF-κB ligand
- shRNA:
-
Short hairpin RNA
- TRAP:
-
Tartrate-resistant acid phosphatase
References
Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655–1664. doi:10.1056/NEJMra030831
Yoneda T (2000) Cellular and molecular basis of preferential metastasis of breast cancer to bone. J Orthop Sci 5:75–81. doi:10.1007/s007760050012
Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56. doi:10.1038/35065016
Coleman RE (2002) The clinical use of bone resorption markers in patients with malignant bone disease. Cancer 94:2521–2533. doi:10.1002/cncr.10522
Kozlow W, Guise TA (2005) Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 10:169–180. doi:10.1007/s10911-005-5399-8
Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249s. doi:10.1158/1078-0432.CCR-06-0931
Taylor ME (2002) Breast cancer: chest wall recurrences. Curr Treat Options Oncol 3:175–177. doi:10.1007/s11864-002-0063-7
Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174. doi:10.1038/nrc745
Fingleton B (2006) Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 11:479–491. doi:10.2741/1811
Loo WT, Cheung MN, Chow LW (2004) Production of matrix metalloproteinases in specific subpopulations of human-patient breast cancer invading in three dimensional culture system. Life Sci 76:743–752. doi:10.1016/j.lfs.2004.06.027
Balduyck M, Zerimech F, Gouyer V et al (2000) Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 18:171–178. doi:10.1023/A:1006762425323
Toole BP, Linsenmayer TF (1977) Newer knowledge of skeletogenesis: macromolecular transitions in the extracellular matrix. Clin Orthop Relat Res 129:258–278
Rose AA, Siegel PM (2006) Breast cancer-derived factors facilitate osteolytic bone metastasis. Bull Cancer 93:931–943
Kahari VM, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp Dermatol 6:199–213. doi:10.1111/j.1600-0625.1997.tb00164.x
Pardo A, Selman M (2005) MMP-1: the elder of the family. Int J Biochem Cell Biol 37:283–288. doi:10.1016/j.biocel.2004.06.017
Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537–549. doi:10.1016/S1535-6108(03)00132-6
Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342. doi:10.1038/nature01658
Holliday LS, Welgus HG, Fliszar CJ et al (1997) Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272:22053–22058. doi:10.1074/jbc.272.35.22053
Baron R, Neff L, Louvard D et al (1985) Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101:2210–2222. doi:10.1083/jcb.101.6.2210
Blair HC, Teitelbaum SL, Ghiselli R et al (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245:855–857. doi:10.1126/science.2528207
Chatterjee D, Chakraborty M, Leit M et al (1992) Sensitivity to vanadate and isoforms of subunits A and B distinguish the osteoclast proton pump from other vacuolar H+ ATPases. Proc Natl Acad Sci USA 89:6257–6261. doi:10.1073/pnas.89.14.6257
Baron R (1989) Molecular mechanisms of bone resorption by the osteoclast. Anat Rec 224:317–324. doi:10.1002/ar.1092240220
Vaes G (1988) Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin Orthop Relat Res 231:239–271
Delaisse JM, Andersen TL, Engsig MT et al (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61:504–513. doi:10.1002/jemt.10374
Everts V, Delaisse JM, Korper W et al (2002) The bone lining cell: its role in cleaning Howship’s lacunae and initiating bone formation. J Bone Miner Res 17:77–90. doi:10.1359/jbmr.2002.17.1.77
Delaisse JM, Eeckhout Y, Neff L et al (1993) (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci 106(Pt 4):1071–1082
Delaisse JM, Eeckhout Y, Vaes G (1988) Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinology 123:264–276
Arguello F, Baggs RB, Frantz CN (1988) A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48:6876–6881
Pollard M, Luckert PH (1985) Effects of dichloromethylene diphosphonate on the osteolytic and osteoplastic effects of rat prostate adenocarcinoma cells. J Natl Cancer Inst 75:949–954
Blackburn JS, Rhodes CH, Coon CI et al (2007) RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res 67:10849–10858. doi:10.1158/0008-5472.CAN-07-1791
Wyatt CA, Geoghegan JC, Brinckerhoff CE (2005) Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res 65:11101–11108. doi:10.1158/0008-5472.CAN-05-2446
Jiang X, Dutton CM, Qi WN et al (2005) siRNA mediated inhibition of MMP-1 reduces invasive potential of a human chondrosarcoma cell line. J Cell Physiol 202:723–730. doi:10.1002/jcp.20162
Petrella BL, Brinckerhoff CE (2006) Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase. Mol Cancer 5:66. doi:10.1186/1476-4598-5-66
Petrella BL, Lohi J, Brinckerhoff CE (2005) Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma. Oncogene 24:1043–1052. doi:10.1038/sj.onc.1208305
Meier F, Nesbit M, Hsu MY et al (2000) Human melanoma progression in skin reconstructs: biological significance of bFGF. Am J Pathol 156:193–200
Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169–180. doi:10.1007/BF00666038
Benbow U, Schoenermark MP, Orndorff KA et al (1999) Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid. Clin Exp Metastasis 17:231–238. doi:10.1023/A:1006639214618
Brinckerhoff CE, Matrisian LM (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3:207–214. doi:10.1038/nrm763
Bridge AJ, Pebernard S, Ducraux A et al (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 34:263–264. doi:10.1038/ng1173
Pebernard S, Iggo RD (2004) Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 72:103–111. doi:10.1111/j.1432-0436.2004.07202001.x
Behrens P, Rothe M, Wellmann A et al (2001) The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194:43–50. doi:10.1002/path.844
Gimbrone MA Jr, Leapman SB, Cotran RS et al (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261–276. doi:10.1084/jem.136.2.261
Gupta GP, Nguyen DX, Chiang AC et al (2007) Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446:765–770. doi:10.1038/nature05760
Saunders WB, Bayless KJ, Davis GE (2005) MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 118:2325–2340. doi:10.1242/jcs.02360
Pozrikidis C, Farrow DA (2003) A model of fluid flow in solid tumors. Ann Biomed Eng 31:181–194. doi:10.1114/1.1540103
Benelli R, Albini A (1999) In vitro models of angiogenesis: the use of Matrigel. Int J Biol Markers 14:243–246
Im E, Venkatakrishnan A, Kazlauskas A (2005) Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 16:3488–3500. doi:10.1091/mbc.E04-11-1029
Goerge T, Barg A, Schnaeker EM et al (2006) Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation. Cancer Res 66:7766–7774. doi:10.1158/0008-5472.CAN-05-3897
Rodan GA (2003) The development and function of the skeleton and bone metastases. Cancer 97:726–732. doi:10.1002/cncr.11147
Hill PA, Docherty AJ, Bottomley KM et al (1995) Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 308(Pt 1):167–175
Holliday LS, Welgus HG, Hanna J et al (2003) Interstitial collagenase activity stimulates the formation of actin rings and ruffled membranes in mouse marrow osteoclasts. Calcif Tissue Int 72:206–214. doi:10.1007/s00223-002-1008-7
Boyde A, Maconnachie E, Reid SA et al (1986) Scanning electron microscopy in bone pathology: review of methods, potential and applications. Scan Electron Microsc 4:1537–1554
Taube T, Elomaa I, Blomqvist C et al (1994) Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 15:161–166. doi:10.1016/8756-3282(94)90703-X
Cicek M, Oursler MJ (2006) Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Rev 25:635–644. doi:10.1007/s10555-006-9035-x
Garrett IR (1993) Bone destruction in cancer. Semin Oncol 20:4–9
Yoneda T, Sasaki A, Mundy GR (1994) Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat 32:73–84. doi:10.1007/BF00666208
Okushiba S, Minagawa H, Shimizu M et al (2001) A case of spindle cell carcinoma of the breast—long survival achieved by multiple surgical treatment. Breast Cancer 8:238–242
Jiang Y, Xu W, Lu J et al (2001) Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Biochem Biophys Res Commun 286:1123–1130. doi:10.1006/bbrc.2001.5521
Kameyama K (1996) Expression of MMP-1 in the capsule of thyroid cancer—relationship with invasiveness. Pathol Res Pract 192:20–26
Zeng ZZ, Jia Y, Hahn NJ et al (2006) Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res 66:8091–8099. doi:10.1158/0008-5472.CAN-05-4400
Acknowledgments
We would like to extend thanks to Dr. C. Harker Rhodes for IHC consultation and Dr. Steve Fiering for thoughtful ideas. Grant support: NIH grants AR26599 and CA77267 (C. E. Brinckerhoff) and NIH grant T32-CA009658 (S. M. Eck).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eck, S.M., Hoopes, P.J., Petrella, B.L. et al. Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Res Treat 116, 79–90 (2009). https://doi.org/10.1007/s10549-008-0085-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0085-3